Table 5 |
|||
|
Perceived barriers for managing CVD patients |
|||
|
Family Physicians |
General Internists |
Overall |
|
|
|
|||
|
Adverse effects of drugs |
50.4% |
52.3% |
51.1% |
|
|
|||
|
Patient adherence |
73.7% |
74.1% |
73.8% |
|
|
|||
|
Presence of co-morbid conditions |
59.6% |
56.3% |
58.4% |
|
|
|||
|
Cost of medications |
89.4% |
87.7% |
88.8% |
|
|
|||
|
Number of drugs needed for adequate blood pressure control |
74.0% |
75.1% |
74.4% |
|
|
|||
|
Patient understanding of treatment goals |
53.8% |
51.4% |
52.9% |
|
|
|||
|
Adequate time to address lifestyle issues with patients |
52.2% |
55.4% |
53.4% |
|
|
|||
|
Adequate patient-education tools regarding lifestyle issues |
44.0% |
47.1% |
45.1% |
|
|
|||
|
Knowledge and skills to provide dietary recommendations |
46.2% |
47.8% |
46.9% |
|
|
|||
|
Knowledge and skills to facilitate patient adherence |
44.7% |
52.0% |
47.4% |
|
|
|||
|
Each item was rated on a 1–5 Likert scale (1 = not a significant barrier, 5 = significant barrier). Percentage reported represents those who indicated a 4 or 5 on the scale. CVD, cardiovascular disease Overall refers to the combined results of family physicians and general internists |
|||
|
Doroodchi et al. BMC Family Practice 2008 9:42 doi:10.1186/1471-2296-9-42 |
|||